Cargando…
Genomic diversity contributes to the neuroinvasiveness of the Yellow fever French neurotropic vaccine
Mass vaccination with the live attenuated vaccine YF-17D is the current way to prevent infection with Yellow fever virus (YFV). However, 0.000012–0.00002% of vaccinated patients develop post-vaccination neurological syndrome (YEL-AND). Understanding the factors responsible for neuroinvasion, neurotr...
Autores principales: | Bakoa, Florian, Préhaud, Christophe, Beauclair, Guillaume, Chazal, Maxime, Mantel, Nathalie, Lafon, Monique, Jouvenet, Nolwenn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8076279/ https://www.ncbi.nlm.nih.gov/pubmed/33903598 http://dx.doi.org/10.1038/s41541-021-00318-3 |
Ejemplares similares
-
Midgut barriers prevent the replication and dissemination of the yellow fever vaccine in Aedes aegypti
por: Danet, Lucie, et al.
Publicado: (2019) -
Comparative analysis of neuroinvasion by Japanese encephalitis virulent and vaccine viral strains in an in vitro model of human blood-brain barrier
por: Khou, Cécile, et al.
Publicado: (2021) -
The neuroinvasiveness, neurotropism, and neurovirulence of SARS-CoV-2
por: Bauer, Lisa, et al.
Publicado: (2022) -
Vaccine and Wild-Type Strains of Yellow Fever Virus Engage Distinct Entry Mechanisms and Differentially Stimulate Antiviral Immune Responses
por: Fernandez-Garcia, Maria Dolores, et al.
Publicado: (2016) -
THE TRANSMISSION OF NEUROTROPIC YELLOW FEVER VIRUS BY STEGOMYIA MOSQUITOES
por: Davis, Nelson C., et al.
Publicado: (1932)